You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning

Article metrics

Article menu

Download PDFPDF

Research Article
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2025

AbstractFullPdf
Dec 2019110
Jan 2020660
Feb 2020332
Mar 202028282
Apr 202010100
May 202015154
Jun 2020991
Jul 2020550
Aug 2020662
Sep 202021213
Oct 202019193
Nov 202013131
Dec 202012122
Jan 2021880
Feb 2021773
Mar 202111113
Apr 2021781
May 2021552
Jun 202110100
Jul 202112123
Aug 2021991
Sep 202112123
Oct 202122226
Nov 2021991
Dec 202123234
Jan 202225275
Feb 202223256
Mar 202220222
Apr 202227274
May 2022414113
Jun 202238382
Jul 202232331
Aug 202243433
Sep 202233330
Oct 202230304
Nov 2022141610
Dec 202227272
Jan 202321211
Feb 202335355
Mar 202313141
Apr 202313142
May 202328284
Jun 202317170
Jul 2023363611
Aug 202326263
Sep 202316162
Oct 202353532
Nov 202350500
Dec 2023404010
Jan 202423243
Feb 202419191
Mar 202428297
Apr 2024505320
May 202419197
Jun 2024515010
Jul 202461627
Aug 202425239
Sep 202412121
Oct 2024222212
Nov 202429306
Dec 2024293013
Jan 202524249
Feb 202526268
Mar 2025333310
Apr 2025767618
May 202538388
Jun 202525253
Jul 2025110
Oct 2025110
Total15761593292